VAERS reports by lot

GSK RSV lot 58160-0848-11: VAERS reports

27 VAERS reports list lot 58160-0848-11 as a GSK RSV vaccine, received between 2023-08-25 and 2024-07-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3023%
Musculoskeletal2721%
General / Systemic (non-local)2620%
Neurological1915%
Allergic / Anaphylactic65%
Gastrointestinal65%
Dermatological (non-injection-site)65%
Cardiac / Cardiovascular43%
Psychiatric / Neuropsychiatric43%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Michigan4
Oregon3
Texas3
Florida2
Kansas2
Colorado1
Arizona1
Pennsylvania1
Iowa1
New Jersey1
New York1

Reports by month received

2023-081
2023-0910
2023-107
2023-111
2023-124
2024-012
2024-021
2024-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.